New Gene Therapy Successfully Treats Hereditary Deafness

Researchers have successfully utilized gene therapy to treat a condition called DFNB9, caused by mutations in the OTOF gene.

This gene is vital for producing the otoferlin protein, which helps send sound signals to the brain.

Unlike traditional cochlear implants that rely on electronic hardware, this treatment addresses the biological root cause.

In clinical trials, scientists used a modified adeno-associated virus as a delivery vehicle to inject a functional OTOF gene directly into the inner ear.

Though still in the trial phase, this success offers a promising path toward restoring natural hearing without the need for external devices, marking a historic milestone in genetic medicine.